Macrophage Functions in Psoriasis: Lessons from Mouse Models
暂无分享,去创建一个
[1] I. Aljuffali,et al. RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models , 2024, Drug design, development and therapy.
[2] Zhengwei Zou,et al. MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic keratinocyte in psoriasis. , 2024, Inflammation.
[3] Y. Zhen,et al. Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization. , 2024, International immunopharmacology.
[4] C. Jonak,et al. Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα , 2024, Dermatology and therapy.
[5] Haoting Li,et al. A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation , 2024, Nature communications.
[6] Chwan-Fwu Lin,et al. The anti‐inflammatory activity of flavonoids and alkaloids from Sophora flavescens alleviates psoriasiform lesions: Prenylation and methoxylation beneficially enhance bioactivity and skin targeting , 2024, Phytotherapy research : PTR.
[7] Marcarious M. Tantuoyir,et al. Exploring the polarization of M1 and M2 macrophages in the context of skin diseases. , 2024, Molecular biology reports.
[8] A. Alvarado-Navarro,et al. Etiopathogenesis of Psoriasis: Integration of Proposed Theories , 2024, Immunological investigations.
[9] Wanying Lan,et al. The roles of tissue resident macrophages in health and cancer , 2024, Experimental hematology & oncology.
[10] A. Gombart,et al. Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis , 2024, The Journal of clinical investigation.
[11] Zongguang Tai,et al. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets , 2024, Frontiers in immunology.
[12] Haitao Li,et al. Yogurt Alleviates Imiquimod-Induced Psoriasis by Activating the Lactate/GPR81 Signaling Axis in Mice. , 2024, Journal of agricultural and food chemistry.
[13] Xiaoli Min,et al. Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles , 2024, Theranostics.
[14] Yuying Jia,et al. Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification , 2023, International journal of general medicine.
[15] Yujun Song,et al. A Nanoinhibitor Targeting cGAS-STING Pathway to Reverse the Homeostatic Imbalance of Inflammation in Psoriasis. , 2023, Angewandte Chemie.
[16] Y. Yanase,et al. Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching , 2023, Frontiers in immunology.
[17] Qian Zhang,et al. Advances in the study of macrophage polarization in inflammatory immune skin diseases , 2023, Journal of Inflammation.
[18] Jing Chen,et al. Keratinocyte derived HMGB1 aggravates psoriasis dermatitis via facilitating inflammatory polarization of macrophages and hyperproliferation of keratinocyte. , 2023, Molecular immunology.
[19] Weiwei Chen,et al. Stress aggravates imiquimod-induced psoriasiform inflammation by promoting M1 macrophage polarization. , 2023, International immunopharmacology.
[20] S. Künzel,et al. Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis , 2023, The Journal of pathology.
[21] Yan Wang,et al. Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Mouse Model via Reducing Macrophage Infiltration and Inhibiting Glycolysis , 2023, Journal of inflammation research.
[22] K. Bryniarski,et al. Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared? , 2023, Frontiers in Cell and Developmental Biology.
[23] Zengyang Yu,et al. The role of microRNA in psoriasis: A review , 2023, Experimental dermatology.
[24] Luxian Zhou,et al. Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation , 2023, The Journal of dermatological treatment.
[25] S. Motegi,et al. TRPV4 regulates the development of psoriasis by controlling ATP expression in keratinocytes and the neuroimmune system. , 2023, The Journal of investigative dermatology.
[26] Shiyu Hu,et al. The macrophage polarization in inflammatory dermatosis and its potential drug candidates. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[27] R. Tan,et al. Macrophages mediate psoriasis via Mincle-dependent mechanism in mice , 2023, Cell death discovery.
[28] Yi Cao,et al. Study of dietary‑induced progression of psoriasis‑like mice based on gut macrophage polarization , 2023, Experimental and therapeutic medicine.
[29] B. Chiang,et al. M2‐like macrophages polarized by Foxp3− Treg‐of‐B cells ameliorate imiquimod‐induced psoriasis , 2023, Journal of cellular and molecular medicine.
[30] T. Powell-Wiley,et al. Comparison of the dietary omega-3 fatty acids impact on murine psoriasis-like skin inflammation and associated lipid dysfunction. , 2023, The Journal of nutritional biochemistry.
[31] Fu-Tong Liu,et al. PD-L1 Enhanced by cis-Urocanic Acid on Langerhans Cells Inhibits Vγ4+ γδT17 Cells in Psoriatic Skin Inflammation. , 2023, The Journal of investigative dermatology.
[32] Kutty Selva Nandakumar,et al. Comparative studies on mannan and imiquimod induced experimental plaque psoriasis inflammation in inbred mice , 2023, Clinical and experimental immunology.
[33] X. Fan,et al. Inhibition of serum and glucocorticoid-regulated protein kinase-1 aggravates imiquimod-induced psoriatic dermatitis and enhances proinflammatory cytokine expression via the NF-kappaB pathway. , 2023, The Journal of investigative dermatology.
[34] K. Safranow,et al. Adiponectin, Leptin and Resistin in Patients with Psoriasis , 2023, Journal of clinical medicine.
[35] Wang Hee Lee,et al. Hyaluronic Acid Nanoparticles as a Topical Agent for Treating Psoriasis. , 2022, ACS nano.
[36] P. Lio,et al. Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases , 2022, Current Allergy and Asthma Reports.
[37] Weiguo Sun,et al. Etanercept alleviates psoriasis by reducing the Th17/Treg ratio and promoting M2 polarization of macrophages , 2022, Immunity, inflammation and disease.
[38] K. Khosrotehrani,et al. Macrophages in Skin Wounds: Functions and Therapeutic Potential , 2022, Biomolecules.
[39] Adam Wroński,et al. Impact of ROS-Dependent Lipid Metabolism on Psoriasis Pathophysiology , 2022, International journal of molecular sciences.
[40] A. Regev,et al. Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling. , 2022, Immunity.
[41] L. Macia,et al. Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development. , 2022, Cell reports.
[42] N. Okiyama,et al. The role of programmed cell death ligand-1 on Langerhans cells in the regulation of psoriasis. , 2022, The Journal of investigative dermatology.
[43] M. Winnefeld,et al. Macrophages are polarized towards an inflammatory phenotype by their aged microenvironment in the human skin. , 2022, The Journal of investigative dermatology.
[44] Valmore Bermúdez,et al. Exploring the Links between Obesity and Psoriasis: A Comprehensive Review , 2022, International journal of molecular sciences.
[45] Y. Tada,et al. Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis , 2022, Frontiers in Immunology.
[46] A. Lusis,et al. Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization , 2022, International journal of molecular sciences.
[47] Xushan Cha,et al. Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis , 2022, Bioengineered.
[48] K. Sugiura. Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond , 2022, Dermatology and Therapy.
[49] Kan Ze,et al. Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice by targeting Langerhans cells. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[50] Nicoleta Anton,et al. Update on the etiopathogenesis of psoriasis (Review) , 2022, Experimental and therapeutic medicine.
[51] Mengyao Wang,et al. The Role of Helper T Cells in Psoriasis , 2021, Frontiers in Immunology.
[52] J. Gudjonsson,et al. Mouse Models of Psoriasis: A Comprehensive Review. , 2021, The Journal of investigative dermatology.
[53] Yajing Gao,et al. Hsa_circ_0004287 inhibits macrophage-mediated inflammation in an N6-methyladenosine-dependent manner in atopic dermatitis and psoriasis. , 2021, The Journal of allergy and clinical immunology.
[54] Nitwara Wikan,et al. Anti-psoriatic and anti-inflammatory effects of Kaempferia parviflora in keratinocytes and macrophage cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[55] Ling-juan Zhang,et al. Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity , 2021, JID innovations.
[56] K. Nakai,et al. What Are Reactive Oxygen Species, Free Radicals, and Oxidative Stress in Skin Diseases? , 2021, International journal of molecular sciences.
[57] Yi Zhao,et al. Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation. , 2021, Immunity.
[58] G. Novelli,et al. Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis , 2021, Genes.
[59] D. Kang,et al. Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation , 2021, Frontiers in Immunology.
[60] F. Sánchez‐Madrid,et al. Antibodies Enhance the Suppressive Activity of Extracellular Vesicles in Mouse Delayed-Type Hypersensitivity , 2021, Pharmaceuticals.
[61] Chun-Ming Huang,et al. Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis , 2021, Pharmaceutics.
[62] Johannes U. Mayer,et al. Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population , 2021, eLife.
[63] N. Rosenthal,et al. Macrophages in dermatology: pathogenic roles and targeted therapeutics , 2021, Archives of Dermatological Research.
[64] E. Kerzberg,et al. Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis , 2021, Frontiers in Immunology.
[65] E. Muñoz-Elías,et al. Differential Changes in Inflammatory Mononuclear Phagocyte and T Cell Profiles within Psoriatic Skin during Treatment with Guselkumab versus Secukinumab. , 2021, The Journal of investigative dermatology.
[66] S. Teichmann,et al. Developmental cell programs are co-opted in inflammatory skin disease , 2021, Science.
[67] Xiang Chen,et al. The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis , 2020, Journal of cellular and molecular medicine.
[68] P. Askenase,et al. Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains , 2020, International journal of molecular sciences.
[69] L. Macia,et al. Immune Modulation of Monocytes Dampens the IL-17+ γδ T cell Response and Associated Psoriasis Pathology in Mice. , 2020, The Journal of investigative dermatology.
[70] I. Iskandar,et al. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender * , 2020, The British journal of dermatology.
[71] N. Sweiss,et al. TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin‐to‐joint crosstalk in psoriatic arthritis , 2020, European Journal of Immunology.
[72] L. Carvalho,et al. Mononuclear Phagocyte Activation Is Associated With the Immunopathology of Psoriasis , 2020, Frontiers in Immunology.
[73] A. Kerstan,et al. Current Developments in the Immunology of Psoriasis , 2020, The Yale journal of biology and medicine.
[74] Y. J. Kang,et al. 4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis , 2020, The Journal of Immunology.
[75] Hong-Yu Zhang,et al. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. , 2019, Life sciences.
[76] Wei Wei,et al. Murine models of psoriasis and its applications in drug development. , 2019, Journal of pharmacological and toxicological methods.
[77] F. Sánchez‐Madrid,et al. Syngeneic red blood cell–induced extracellular vesicles suppress delayed‐type hypersensitivity to self‐antigens in mice , 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[78] C. Dinarello,et al. The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis , 2019, International journal of molecular sciences.
[79] B. Gibbs,et al. Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases , 2019, Front. Immunol..
[80] J. Farber,et al. IL‐23‐ and Imiquimod‐Induced Models of Experimental Psoriasis in Mice , 2019, Current protocols in immunology.
[81] P. Askenase,et al. Delayed-Type Hypersensitivity Underlying Casein Allergy Is Suppressed by Extracellular Vesicles Carrying miRNA-150 , 2019, Nutrients.
[82] S. Gauld,et al. Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation , 2019, Scientific Reports.
[83] Adriana Rendon,et al. Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.
[84] Mayuko Yamamoto,et al. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production. , 2019, Journal of dermatological science.
[85] Sungwon Jung,et al. Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization , 2019, The Journal of dermatology.
[86] Yu-Wen Su,et al. Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation , 2018, Mediators of inflammation.
[87] R. Haba,et al. Macrophages express βKlotho in skin lesions of psoriatic patients and the skin of imiquimod‐treated mice , 2018, The Journal of dermatology.
[88] S. Brain,et al. Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[89] P. Askenase,et al. Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes , 2018, International journal of molecular sciences.
[90] Min‐Geol Lee,et al. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model. , 2018, Journal of dermatological science.
[91] Ting Liu,et al. The Peritoneal Macrophages in Inflammatory Diseases and Abdominal Cancers. , 2018, Oncology research.
[92] C. Griffiths,et al. Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin‐17 , 2018, The British journal of dermatology.
[93] Y. Sidi,et al. The contribution of feedback loops between miRNAs, cytokines and growth factors to the pathogenesis of psoriasis , 2018, Experimental dermatology.
[94] Maxim N. Artyomov,et al. Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis , 2018, Nature.
[95] J. Krueger,et al. Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment , 2018, Therapeutic advances in chronic disease.
[96] K. Otsu,et al. p38α signaling in Langerhans cells promotes the development of IL-17–producing T cells and psoriasiform skin inflammation , 2018, Science Signaling.
[97] Linnan Zhu,et al. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis , 2018, Protein & Cell.
[98] L. Eidsmo,et al. Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions , 2018, Front. Immunol..
[99] S. Jalkanen,et al. The Macrophage Mannose Receptor Regulate Mannan-Induced Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis-Like Disease Models , 2018, Front. Immunol..
[100] H. Hammad,et al. Langerhans Cells: Sensing the Environment in Health and Disease , 2018, Front. Immunol..
[101] G. Farronato,et al. Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? , 2018, Journal of immunology research.
[102] A. Paun,et al. Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment , 2018, The Journal of experimental medicine.
[103] L. Tsoi,et al. Psoriasis: a mixed autoimmune and autoinflammatory disease. , 2017, Current opinion in immunology.
[104] A. Vallejo,et al. Langerhans Cells—Programmed by the Epidermis , 2017, Front. Immunol..
[105] Marta Moskot,et al. Models in the Research Process of Psoriasis , 2017, International journal of molecular sciences.
[106] R. Pouliot,et al. Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis , 2017, Mediators of inflammation.
[107] T. Tsai,et al. Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness , 2017, Therapeutic advances in musculoskeletal disease.
[108] W. Lambert,et al. Langerhans cell: exciting developments in health and disease , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[109] K. Nagao,et al. Langerhans Cells - The Macrophage in Dendritic Cell Clothing. , 2017, Trends in immunology.
[110] R. Haba,et al. IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice , 2017, Scientific Reports.
[111] D. Kaplan. Ontogeny and function of murine epidermal Langerhans cells , 2017, Nature Immunology.
[112] T. Dainichi,et al. Inhibition of IL‐17–committed T cells in a murine psoriasis model by a vitamin D analogue , 2017, The Journal of allergy and clinical immunology.
[113] C. Xiao,et al. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis. , 2017, Journal of dermatological science.
[114] O. Colegio,et al. The role of macrophages in skin homeostasis , 2017, Pflügers Archiv - European Journal of Physiology.
[115] S. Ludwig,et al. Macrophage‐mediated psoriasis can be suppressed by regulatory T lymphocytes , 2016, The Journal of pathology.
[116] D. M. Elizondo,et al. Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor , 2016, Journal of leukocyte biology.
[117] Yuquan Wei,et al. IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis , 2016, The Journal of Immunology.
[118] R. Sabat,et al. Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations , 2016, Reviews in Endocrine and Metabolic Disorders.
[119] J. Rossjohn,et al. CD1a on Langerhans cells controls inflammatory skin diseases , 2016, Nature Immunology.
[120] Maxim N. Artyomov,et al. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.
[121] Shinichi Sato,et al. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. , 2016, Journal of dermatological science.
[122] F. Akın,et al. Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris , 2016, Annals of dermatology.
[123] F. Ginhoux,et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function , 2015, Nature Immunology.
[124] M. Bajénoff,et al. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis , 2015, The Journal of Immunology.
[125] P. Askenase,et al. Macrophages play an essential role in antigen‐specific immune suppression mediated by T CD8+ cell‐derived exosomes , 2015, Immunology.
[126] Delphine J. Lee,et al. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease , 2015, The Journal of Immunology.
[127] M. Sanak,et al. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells , 2015, PloS one.
[128] Kutty Selva Nandakumar,et al. Reactive Oxygen Species in Psoriasis and Psoriasis Arthritis: Relevance to Human Disease , 2015, International Archives of Allergy and Immunology.
[129] F. Geissmann,et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.
[130] R. Holmdahl,et al. Mannan induces ROS-regulated, IL-17A–dependent psoriasis arthritis-like disease in mice , 2014, Proceedings of the National Academy of Sciences.
[131] F. Aubin,et al. Relationships between Adipose Tissue and Psoriasis, with or without Arthritis , 2014, Front. Immunol..
[132] B. Malissen,et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. , 2014, The Journal of investigative dermatology.
[133] C. Putterman,et al. Targeting TNF and Its Family Members in Autoimmune/Inflammatory Disease , 2014, Mediators of inflammation.
[134] Hyung-ran Kim,et al. Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function , 2014, PloS one.
[135] Yuquan Wei,et al. IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production , 2014, The Journal of Immunology.
[136] B. Malissen,et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. , 2013, Immunity.
[137] Dong Yu,et al. A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis. , 2013, The Journal of investigative dermatology.
[138] Jun Lu,et al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. , 2013, The Journal of allergy and clinical immunology.
[139] P. Filipe,et al. Mechanisms of Action of Topical Corticosteroids in Psoriasis , 2012, International journal of endocrinology.
[140] Xiaoxia Zhu,et al. Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions , 2012, PloS one.
[141] R. Feil,et al. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells , 2011, The Journal of experimental medicine.
[142] U. Mrowietz,et al. Oxidative stress in the pathogenesis of psoriasis. , 2009, Free radical biology & medicine.
[143] N. Yawalkar,et al. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. , 2009, Journal of dermatological science.
[144] D. Diaconu,et al. Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis. , 2009, The American journal of pathology.
[145] M. Pasparakis,et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. , 2006, The Journal of clinical investigation.
[146] N. Van Rooijen,et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. , 2006, The Journal of clinical investigation.
[147] R. Clark,et al. Misbehaving macrophages in the pathogenesis of psoriasis. , 2006, The Journal of clinical investigation.
[148] A. Menssen,et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.
[149] W. Jochum,et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.
[150] K. Ghoreschi,et al. Recent advances in understanding psoriasis , 2022 .